Caixa Capital Risc divests Sanifit Therapeutics to Vifor Pharma

CriteriaCaixa's venture capital subsidiary Caixa Capital Risc has sold Sanifit Therapeutics to Vifor Pharma, a global pharmaceutical company.

23 November 2021•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Healthcare M&A Deals Briefs